IP Library Granted Patent US 9,682,169
Granted Patent B2
US 9,682,169 · App. 14/975,039 · Granted Jun 20, 2017

Hydrogels for vocal cord and soft tissue augmentation and repair

Inventors: Steven M. Zeitels (Newton, MA); Robert E. Hillman (Weston, MA); Sandeep Sidram Karajanagi (Malden, MA); Robert S. Langer (Newton, MA)
Assignees: Massachusetts Institute of Technology; The General Hospital Corporation
A61L27/26A61K31/00A61K31/7052A61L27/38A61L27/3834A61L27/50A61L27/52C08J3/075C08J3/246A61L2400/06A61L2430/34C08J2305/08C08J2371/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,682,169
App. No.
14/975,039
Granted
Jun 20, 2017
Kind
B2
Abstract

The present invention provides hydrogels and compositions thereof for vocal cord repair or augmentation, as well as other soft tissue repair or augmentation (e.g., bladder neck augmentation, dermal fillers, breast implants, intervertebral disks, muscle-mass). The hydrogels or compositions thereof are injected into the superficial lamina propria or phonatory epithelium to restore the phonatory mucosa of the vocal cords, thereby restoring a patient's voice. In particular, it has been discovered that hydrogels with an elastic shear modulus of approximately 25 Pa are useful in restoring the pliability of the phonatory mucosa. The invention also provides methods of preparing and using the inventive hydrogels.

Claims (28)

1. A method of treating a subject having a phonatory mucosa with diminished functional vibratory capacity and diminished phonation, the method comprising

locating a phonatory mucosa with diminished functional vibratory capacity in the subject; and

injecting into the phonatory mucosa a hydrogel material that comprises an elastic shear modulus ranging from about 15 to about 121 Pa measured at a frequency of 10 Hz in an amount effective to increase functional vibratory capacity of the phonatory mucosa and improve phonation;

wherein the hydrogel material comprises a first cross-linked polymer and a second polymer,

wherein the first cross-linked polymer comprises a cross-linked form of a polyether, polypeptide, or polysaccharide, and

wherein the second polymer is selected from the group consisting of polyethers, polyacrylates, polyesters, polyanhydrides, polyols, polypeptides, polyvinyl alcohols, proteins, polysaccharides, gelatins, elastins, collagens, celluloses, methylcelluloses, hyaluronic acid, dextrans, alginates, and derivatives thereof,

and wherein the hydrogel material comprises an interpenetrating or semi-interpenetrating network of the first and second polymers.

2. The method of claim 1 , wherein the phonatory mucosa is a part of a vocal cord of the subject.

3. The method of claim 2 , wherein the hydrogel material is injected into a superficial lamina propria of the phonatory mucosa.

4. The method of claim 1 , wherein the phonatory mucosa is part of the larynx.

5. The method of claim 1 , wherein a superficial lamina propria is missing from the phonatory mucosa.

6. The method of claim 1 , wherein the first cross-linked polymer comprises a cross-linked form of polyethylene glycol, polylysine, or hyaluronic acid.

7. The method of claim 1 , wherein the hydrogel material comprises crosslinked polyethylene glycol diacrylate (PEG-DA) and polyethylene glycol (PEG) in a ratio of about 30:70.

8. The method of claim 1 , wherein the hydrogel material has an elastic shear modulus ranging from about 15 to about 35 Pa measured at a frequency of 10 Hz.

9. The method of claim 1 , wherein the hydrogel material has an elastic shear modulus ranging from about 20 to about 30 Pa measured at a frequency of 10Hz.

10. The method of claim 1 , wherein the hydrogel material has an elastic shear modulus ranging from about 21 to about 25 Pa measured at a frequency of 10 Hz.

11. The method of claim 1 , wherein the first cross-linked polymer comprises an acrylated polymer or a methacrylated polymer of polyethylene glycol, polylysine, or hyaluronic acid.

12. The method of claim 1 , wherein the first cross-linked polymer comprises polyethylene glycol diacrylate (PEG-DA); and

the second polymer is selected from the group consisting of polyethylene glycol (PEG), polyols, polyacrylates, polypeptides, poly(lysine), gelatins, elastins, collagens, celluloses, methylcelluloses, polysaccharides, and derivatives thereof.

13. The method of claim 12 , wherein the second polymer comprises polyethylene glycol (PEG).

14. The method of claim 13 , wherein the molecular weight of the PEG-DA is about 10 to about 20 kDa and the molecular weight of the PEG is about 10 to about 20 kDa.

15. The method of claim 12 , wherein the second polymer comprises a polysaccharide.

16. The method of claim 15 , wherein the polysaccharide is selected from the group consisting of hyaluronic acids, dextrans, and alginates.

17. The method of claim 12 , wherein the second polymer comprises a collagen.

18. The method of claim 1 , wherein the

first cross-linked polymer comprises hyaluronic acid methacrylate;

the second polymer is selected from the group consisting of polyethylene glycol (PEG), polypeptides, hyaluronic acid (HA), dextrans, alginates, gelatins, elastins, collagens, celluloses, methylcelluloses, and derivatives thereof; and

wherein the hydrogel material comprises an interpenetrating network of the polymers.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: ZEITELS, STEVEN M.; HILLMAN, ROBERT E.
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 042170/0660 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2016
From: KARAJANAGI, SANDEEP SIDRAM; LANGER, ROBERT S.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 040663/0652 →
Continuity (3)
Continuation 12553800 · Sep 3, 2009
Provisional Application 61094237 · Sep 4, 2008
Related Publication 20160175483A1 · Jun 23, 2016